Literature DB >> 11193794

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

D J Selkoe1.   

Abstract

A central challenge of research on Alzheimer's disease (AD) is to assemble the enormous body of scientific observations about the disorder, some of them seemingly in conflict with others, into a coherent and credible mechanism of pathogenesis. In this article, I attempt to synthesize the disparate findings on AD into a unified sequence that essentially begins with alterations in the production or clearance of the amyloid beta-protein (A beta). Mounting evidence from many laboratories supports an A beta accumulation in limbic and association cortices as the fundamental initiator of the disease, with attendant therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193794     DOI: 10.1111/j.1749-6632.2000.tb05554.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  172 in total

1.  Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis.

Authors:  A Chakrabartty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease.

Authors:  Michael R Sierks; Gaurav Chatterjee; Claire McGraw; Srinath Kasturirangan; Philip Schulz; Shalini Prasad
Journal:  Integr Biol (Camb)       Date:  2011-11-10       Impact factor: 2.192

3.  Interaction of tau protein with model lipid membranes induces tau structural compaction and membrane disruption.

Authors:  Emmalee M Jones; Manish Dubey; Phillip J Camp; Briana C Vernon; Jacek Biernat; Eckhard Mandelkow; Jaroslaw Majewski; Eva Y Chi
Journal:  Biochemistry       Date:  2012-03-14       Impact factor: 3.162

Review 4.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

5.  Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells.

Authors:  Yan-Fang Xian; Zhi-Xiu Lin; Qing-Qiu Mao; Siu-Po Ip; Zi-Ren Su; Xiao-Ping Lai
Journal:  Cell Mol Neurobiol       Date:  2011-11-01       Impact factor: 5.046

6.  Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration.

Authors:  Jill S Wentzell; Bonnie J Bolkan; Katia Carmine-Simmen; Tracy L Swanson; Derek T Musashe; Doris Kretzschmar
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

7.  Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. II. In vitro arachnoid outflow model.

Authors:  David W Holman; Vartan Kurtcuoglu; Deborah M Grzybowski
Journal:  J R Soc Interface       Date:  2010-03-24       Impact factor: 4.118

Review 8.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

Review 9.  Positron emission tomography radioligands for in vivo imaging of Aβ plaques.

Authors:  N Scott Mason; Chester A Mathis; William E Klunk
Journal:  J Labelled Comp Radiopharm       Date:  2013 Mar-Apr       Impact factor: 1.921

10.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.